First Script saw continued decreasing opioid trends across our retail and mail-order programs in 2019, even while overall prescription trends saw a slight upward shift in utilization per claim and cost per claim. Even with these changes, opioids remain the #1 therapeutic class by usage and cost, however, 2019 marked the largest reduction of the last 5 years in the percentage of opioid scripts with greater than or equal to 90 MED. View the video blog here.
Visit Us at the Exhibit Booth Northeast is an eve
Specialty Networks Play a Key Role in Fighting Opioid Misuse For all the progress our nation has made in reducing opioid prescriptions, m
As ballots continue to be counted around the country, with some races still too close to call, voters were much more certain on their support for m
Kaleo, the makers of Evzio, have recently discontinued the prod
Evidence-based medicine is a mainstay in the workers compensation industry, and those aiming to treat workers with COVID-19 are relying on an
As featured on the workcompwire.com blog, this piece was contributed by Tammy Bradly, Vice President, Clinical Product Develo